{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T12:58:12Z","timestamp":1788785892378,"version":"build-2803163510"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["EPSPG\/2022\/316"],"award-info":[{"award-number":["EPSPG\/2022\/316"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001637","name":"Trinity College Dublin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001637","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","msard-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.msard.2026.107040","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T08:02:53Z","timestamp":1770364973000},"page":"107040","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter and immune cells in multiple sclerosis"],"prefix":"10.1016","volume":"108","author":[{"given":"Almudena","family":"Ot\u00e1lora-Alcaraz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melody Cui","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Costelloe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugh","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Prenderville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6012-2291","authenticated-orcid":false,"given":"Eric J.","family":"Downer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2026.107040_bib0001","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bbi.2013.10.017","article-title":"NLRP3 inflammasome is activated in mononuclear blood cells from patients with major depressive disorder","volume":"36","author":"Alcocer-Gomez","year":"2014","journal-title":"Brain Behav. Immun."},{"issue":"4","key":"10.1016\/j.msard.2026.107040_bib0002","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175336","article-title":"Impact of human monocyte and macrophage polarization on NLR expression and NLRP3 inflammasome activation","volume":"12","author":"Awad","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0003","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s10072-017-3230-0","article-title":"Impact of short-term cycle ergometer training on quality of life, cognition and depressive symptomatology in multiple sclerosis patients: a pilot study","volume":"39","author":"Barry","year":"2018","journal-title":"Neurol. Sci."},{"issue":"6578","key":"10.1016\/j.msard.2026.107040_bib0004","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1126\/science.abj8222","article-title":"Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis","volume":"375","author":"Bjornevik","year":"2022","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0005","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2249.2009.03972.x","article-title":"Expression and regulation of the NALP3 inflammasome complex in periodontal diseases","volume":"157","author":"Bostanci","year":"2009","journal-title":"Clin. Exp. Immunol."},{"issue":"8","key":"10.1016\/j.msard.2026.107040_bib0006","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ni.3202","article-title":"The receptor NLRP3 is a transcriptional regulator of TH2 differentiation","volume":"16","author":"Bruchard","year":"2015","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.msard.2026.107040_bib0007","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1093\/brain\/awad045","article-title":"Neuronal NLRP3 inflammasome mediates spreading depolarization-evoked trigeminovascular activation","volume":"146","author":"Chen","year":"2023","journal-title":"Brain"},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107040_bib0008","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.jneuroim.2011.12.008","article-title":"Serum levels of interleukin (IL)-18, IL-23 and IL-17 in Chinese patients with multiple sclerosis","volume":"243","author":"Chen","year":"2012","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0009","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107040_bib0010","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","article-title":"Inflammasome components as new therapeutic targets in inflammatory disease","volume":"25","author":"Coll","year":"2025","journal-title":"Nat. Rev. Immunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107040_bib0011","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s12974-020-01826-0","article-title":"IC100: a novel anti-ASC monoclonal antibody improves functional outcomes in an animal model of multiple sclerosis","volume":"17","author":"Desu","year":"2020","journal-title":"J. Neuroinflamm."},{"issue":"1\u20132","key":"10.1016\/j.msard.2026.107040_bib0012","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jneuroim.2008.11.004","article-title":"The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: the elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy","volume":"207","author":"Dujmovic","year":"2009","journal-title":"J. Neuroimmunol."},{"issue":"Pt B","key":"10.1016\/j.msard.2026.107040_bib0013","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.neuropharm.2016.04.009","article-title":"Toll-like receptor signalling as a cannabinoid target in Multiple Sclerosis","volume":"113","author":"Fitzpatrick","year":"2017","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.msard.2026.107040_bib0014","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1084\/jem.20150237","article-title":"NLR members NLRC4 and NLRP3 mediate sterile inflammasome activation in microglia and astrocytes","volume":"214","author":"Freeman","year":"2017","journal-title":"J. Exp. Med."},{"issue":"12","key":"10.1016\/j.msard.2026.107040_bib0015","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21124223","article-title":"Focus on the role of NLRP3 inflammasome in diseases","volume":"21","author":"Fusco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.msard.2026.107040_bib0016","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1038\/nm.2028","article-title":"Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors","volume":"15","author":"Ghiringhelli","year":"2009","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.msard.2026.107040_bib0017","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","article-title":"Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets","volume":"17","author":"Govindarajan","year":"2020","journal-title":"J. Neuroinflamm."},{"key":"10.1016\/j.msard.2026.107040_bib0018","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.jneuroim.2015.02.006","article-title":"Analysis of apoptosis-related genes in patients with clinically isolated syndrome and their association with conversion to multiple sclerosis","volume":"280","author":"Hagman","year":"2015","journal-title":"J. Neuroimmunol."},{"key":"10.1016\/j.msard.2026.107040_bib0019","doi-asserted-by":"crossref","first-page":"457","DOI":"10.3389\/fimmu.2018.00457","article-title":"The soluble form of toll-like receptor 2 is elevated in serum of multiple sclerosis patients: a novel potential disease biomarker","volume":"9","author":"Hossain","year":"2018","journal-title":"Front. Immunol."},{"issue":"5","key":"10.1016\/j.msard.2026.107040_bib0020","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1191\/1352458504ms1071oa","article-title":"Increased expression of caspase-1 and interleukin-18 in peripheral blood mononuclear cells in patients with multiple sclerosis","volume":"10","author":"Huang","year":"2004","journal-title":"Mult. Scler."},{"issue":"6","key":"10.1016\/j.msard.2026.107040_bib0021","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/iji.12401","article-title":"Association of nod-like receptor protein-3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing-remitting multiple sclerosis","volume":"45","author":"Imani","year":"2018","journal-title":"Int. J. Immunogenet."},{"issue":"26","key":"10.1016\/j.msard.2026.107040_bib0022","doi-asserted-by":"crossref","first-page":"10480","DOI":"10.1073\/pnas.1201836109","article-title":"NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis","volume":"109","author":"Inoue","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.msard.2026.107040_bib0023","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bbi.2012.12.008","article-title":"The inflammasome: pathways linking psychological stress, depression, and systemic illnesses","volume":"31","author":"Iwata","year":"2013","journal-title":"Brain Behav. Immun."},{"issue":"1","key":"10.1016\/j.msard.2026.107040_bib0024","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0022-510X(02)00312-X","article-title":"Quality of life in patients with multiple sclerosis: the impact of fatigue and depression","volume":"205","author":"Janardhan","year":"2002","journal-title":"J. Neurol. Sci."},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0025","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nri2938","article-title":"Immune cell regulation by autocrine purinergic signalling","volume":"11","author":"Junger","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0026","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1007\/s11033-013-3013-5","article-title":"Interleukin 18 gene polymorphism is a risk factor for multiple sclerosis","volume":"41","author":"Karakas Celik","year":"2014","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.msard.2026.107040_bib0027","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3389\/fneur.2018.00135","article-title":"Inflammasome proteins As biomarkers of multiple sclerosis","volume":"9","author":"Keane","year":"2018","journal-title":"Front. Neurol."},{"key":"10.1016\/j.msard.2026.107040_bib0028","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1146\/annurev-immunol-073119-095439","article-title":"Caspases in cell death, inflammation, and pyroptosis","volume":"38","author":"Kesavardhana","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.msard.2026.107040_bib0029","series-title":"The Impact of Food Bioactives on Health: In Vitro and Ex Vivo Models","first-page":"161","article-title":"Peripheral blood mononuclear cells","author":"Kleiveland","year":"2015"},{"issue":"1","key":"10.1016\/j.msard.2026.107040_bib0030","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S1474-4422(22)00289-7","article-title":"Multiple sclerosis progression: time for a new mechanism-driven framework","volume":"22","author":"Kuhlmann","year":"2023","journal-title":"Lancet Neurol."},{"issue":"4","key":"10.1016\/j.msard.2026.107040_bib0031","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1124\/mol.64.4.785","article-title":"Mechanisms of release of nucleotides and integration of their action as P2X- and P2Y-receptor activating molecules","volume":"64","author":"Lazarowski","year":"2003","journal-title":"Mol. Pharmacol."},{"issue":"5","key":"10.1016\/j.msard.2026.107040_bib0032","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1177\/1352458510364196","article-title":"Cerebrospinal fluid ATP metabolites in multiple sclerosis","volume":"16","author":"Lazzarino","year":"2010","journal-title":"Mult. Scler."},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0033","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2990.1993.tb00431.x","article-title":"Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques","volume":"19","author":"Li","year":"1993","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0034","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1034\/j.1600-0404.2001.00356.x","article-title":"IL-18 in patients with multiple sclerosis","volume":"104","author":"Losy","year":"2001","journal-title":"Acta Neurol. Scand."},{"issue":"4","key":"10.1016\/j.msard.2026.107040_bib0035","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1212\/WNL.46.4.907","article-title":"Defining the clinical course of multiple sclerosis: results of an international survey. National Multiple Sclerosis Society (USA) Advisory Committee on Clinical trials of New agents in Multiple Sclerosis","volume":"46","author":"Lublin","year":"1996","journal-title":"Neurology."},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0036","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1212\/WNL.0000000000000560","article-title":"Defining the clinical course of multiple sclerosis: the 2013 revisions","volume":"83","author":"Lublin","year":"2014","journal-title":"Neurology"},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0037","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","article-title":"Pharmacological inhibition of the NLRP3 inflammasome: structure, molecular activation, and inhibitor-NLRP3 interaction","volume":"75","author":"Ma","year":"2023","journal-title":"Pharmacol. Rev."},{"issue":"4","key":"10.1016\/j.msard.2026.107040_bib0038","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1159\/000068322","article-title":"Role and mechanisms of interleukin-1 in the modulation of neurotoxicity","volume":"10","author":"Ma","year":"2002","journal-title":"Neuroimmunomodulation"},{"issue":"5","key":"10.1016\/j.msard.2026.107040_bib0039","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1093\/brain\/awaa084","article-title":"NLRP3 inflammasome as prognostic factor and therapeutic target in primary progressive multiple sclerosis patients","volume":"143","author":"Malhotra","year":"2020","journal-title":"Brain"},{"key":"10.1016\/j.msard.2026.107040_bib0040","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12974-015-0269-9","article-title":"Role of high mobility group box protein 1 (HMGB1) in peripheral blood from patients with multiple sclerosis","volume":"12","author":"Malhotra","year":"2015","journal-title":"J. Neuroinflamm."},{"issue":"2","key":"10.1016\/j.msard.2026.107040_bib0041","doi-asserted-by":"crossref","first-page":"127","DOI":"10.3109\/08916934.2013.866104","article-title":"Up-regulation of inducible heat shock protein-70 expression in multiple sclerosis patients","volume":"47","author":"Mansilla","year":"2014","journal-title":"Autoimmunity"},{"issue":"5","key":"10.1016\/j.msard.2026.107040_bib0042","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/ni.3389","article-title":"T cell-intrinsic ASC critically promotes T(H)17-mediated experimental autoimmune encephalomyelitis","volume":"17","author":"Martin","year":"2016","journal-title":"Nat. Immunol."},{"issue":"26","key":"10.1016\/j.msard.2026.107040_bib0043","doi-asserted-by":"crossref","first-page":"E6065","DOI":"10.1073\/pnas.1722041115","article-title":"Caspase-1 inhibition prevents glial inflammasome activation and pyroptosis in models of multiple sclerosis","volume":"115","author":"McKenzie","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.msard.2026.107040_bib0044","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1128\/CMR.00046-08","article-title":"Pathogen recognition and inflammatory signaling in innate immune defenses","volume":"22","author":"Mogensen","year":"2009","journal-title":"Clin. Microbiol. Rev."},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0045","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/ni.1980","article-title":"Autophagy proteins regulate innate immune responses by inhibiting the release of mitochondrial DNA mediated by the NALP3 inflammasome","volume":"12","author":"Nakahira","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.msard.2026.107040_bib0046","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2024.116667","article-title":"The NLRP3 inflammasome: a central player in multiple sclerosis","volume":"232","author":"Otalora-Alcaraz","year":"2025","journal-title":"Biochem. Pharmacol."},{"issue":"5","key":"10.1016\/j.msard.2026.107040_bib0047","doi-asserted-by":"crossref","first-page":"E538","DOI":"10.1503\/jpn.210016","article-title":"Innate immunity receptors in depression and suicide: upregulated NOD-like receptors containing pyrin (NLRPs) and hyperactive inflammasomes in the postmortem brains of people who were depressed and died by suicide","volume":"46","author":"Pandey","year":"2021","journal-title":"J. Psychiatry Neurosci."},{"issue":"2","key":"10.1016\/j.msard.2026.107040_bib0048","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molimm.2014.10.008","article-title":"Increased inflammasome related gene expression profile in PBMC may facilitate T helper 17 cell induction in multiple sclerosis","volume":"63","author":"Peelen","year":"2015","journal-title":"Mol. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2026.107040_bib0049","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ana.22366","article-title":"Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria","volume":"69","author":"Polman","year":"2011","journal-title":"Ann. Neurol."},{"issue":"6","key":"10.1016\/j.msard.2026.107040_bib0050","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1097\/00002060-199511000-00004","article-title":"Role of bacterial infection in exacerbation of multiple sclerosis","volume":"74","author":"Rapp","year":"1995","journal-title":"Am. J. Phys. Med. Rehabil."},{"issue":"5","key":"10.1016\/j.msard.2026.107040_bib0051","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s00401-016-1617-2","article-title":"Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK","volume":"132","author":"Robinson","year":"2016","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.msard.2026.107040_bib0052","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.3389\/fimmu.2019.02578","article-title":"OLT1177 (Dapansutrile), a selective NLRP3 inflammasome inhibitor, ameliorates experimental autoimmune encephalomyelitis pathogenesis","volume":"10","author":"Sanchez-Fernandez","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.msard.2026.107040_bib0053","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1006\/clim.2000.4851","article-title":"The induction of EAE is only partially dependent on TNF receptor signaling but requires the IL-1 type I receptor","volume":"95","author":"Schiffenbauer","year":"2000","journal-title":"Clin. Immunol."},{"issue":"9","key":"10.1016\/j.msard.2026.107040_bib0054","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045186","article-title":"Distinct licensing of IL-18 and IL-1beta secretion in response to NLRP3 inflammasome activation","volume":"7","author":"Schmidt","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/j.msard.2026.107040_bib0055","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fphar.2015.00262","article-title":"NLRP3 inflammasome and its inhibitors: a review","volume":"6","author":"Shao","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.msard.2026.107040_bib0056","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.4049\/jimmunol.1000217","article-title":"Cutting edge: critical role for PYCARD\/ASC in the development of experimental autoimmune encephalomyelitis","volume":"184","author":"Shaw","year":"2010","journal-title":"J. Immunol."},{"issue":"8441","key":"10.1016\/j.msard.2026.107040_bib0057","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/S0140-6736(85)92801-6","article-title":"Clinical viral infections and multiple sclerosis","volume":"1","author":"Sibley","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/j.msard.2026.107040_bib0058","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/1471-2377-14-128","article-title":"Physical and mental health comorbidity is common in people with multiple sclerosis: nationally representative cross-sectional population database analysis","volume":"14","author":"Simpson","year":"2014","journal-title":"BMC Neurol."},{"key":"10.1016\/j.msard.2026.107040_bib0059","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.msard.2019.01.023","article-title":"Variants in NLRP3 and NLRC4 inflammasome associate with susceptibility and severity of multiple sclerosis","volume":"29","author":"Soares","year":"2019","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"8","key":"10.1016\/j.msard.2026.107040_bib0060","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41577-019-0165-0","article-title":"The NLRP3 inflammasome: molecular activation and regulation to therapeutics","volume":"19","author":"Swanson","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.msard.2026.107040_bib0061","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.737065","article-title":"Dimethyl fumarate alleviates NLRP3 inflammasome activation in microglia and sickness behavior in LPS-challenged mice","volume":"12","author":"Tastan","year":"2021","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.msard.2026.107040_bib0062","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0175053","article-title":"Epstein-Barr virus infection-induced inflammasome activation in human monocytes","volume":"12","author":"Torii","year":"2017","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.msard.2026.107040_bib0063","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02260859","article-title":"A health-related quality of life measure for multiple sclerosis","volume":"4","author":"Vickrey","year":"1995","journal-title":"Qual. Life Res."},{"issue":"1","key":"10.1016\/j.msard.2026.107040_bib0064","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.1038\/s41467-018-04376-5","article-title":"A20 critically controls microglia activation and inhibits inflammasome-dependent neuroinflammation","volume":"9","author":"Voet","year":"2018","journal-title":"Nat. Commun."},{"issue":"12","key":"10.1016\/j.msard.2026.107040_bib0065","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/ni.3015","article-title":"RNA viruses promote activation of the NLRP3 inflammasome through a RIP1-RIP3-DRP1 signaling pathway","volume":"15","author":"Wang","year":"2014","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.msard.2026.107040_bib0066","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2020.577466","article-title":"Serum amyloid A level correlates with T2 lesion volume and cortical volume in patients with multiple sclerosis","volume":"351","author":"Yokote","year":"2021","journal-title":"J. Neuroimmunol."},{"issue":"1","key":"10.1016\/j.msard.2026.107040_bib0067","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13578-024-01256-y","article-title":"Role of NLRP3 inflammasome in central nervous system diseases","volume":"14","author":"Zhang","year":"2024","journal-title":"Cell Biosci."},{"issue":"7","key":"10.1016\/j.msard.2026.107040_bib0068","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1093\/brain\/awx113","article-title":"Loss of 'homeostatic' microglia and patterns of their activation in active multiple sclerosis","volume":"140","author":"Zrzavy","year":"2017","journal-title":"Brain"}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034826000763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:06:10Z","timestamp":1785755170000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034826000763"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":68,"alternative-id":["S2211034826000763"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2026.107040","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated expression of the NLRP3 inflammasome in post-mortem brain white matter and immune cells in multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2026.107040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"107040"}}